Navigation Links
Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology
Date:7/18/2008

nationwide clinical trials of promising new therapies and drugs.

About Trinity Mother Frances Neuroscience Institute

The Trinity Mother Frances Neuroscience Institute, part of Trinity Mother Frances Hospitals and Clinics, offers comprehensive services for the diagnosis and treatment of diseases of the central and peripheral nervous systems. The institute couples the latest technology with compassionate and skilled providers to care for our patients. For more information on services available through Trinity Mother Frances Neuroscience Institute, visit http://tmfneuroscience.com .

Trinity Mother Frances Hospitals and Clinics includes Mother Frances Hospital-Tyler, Mother Frances Hospital-Jacksonville, Trinity Mother Frances Rehabilitation Hospital and Trinity Clinic. Trinity Clinic is the region's preferred multi-specialty physician group serving east, northeast and north-central Texas.

About Texas Oncology

Texas Oncology delivers high quality cancer care with leading-edge technology and the most advanced treatment options available today to help patients achieve "More breakthroughs. More victories." in their fight against cancer, right in their own communities. With more than 270 physicians and 90 total sites of service, Texas Oncology, a pioneer in community-based cancer care, is the largest independent oncology practice nationwide and provides care to more Texans with cancer than any other cancer care provider. In 2007, Texas Oncology treated more than 27,000 of the 95,310 patients diagnosed with cancer in Texas.

Texas Oncology patients are treated with today's most advanced, effective technologies, therapies, and treatments. Texas Oncology patients have the opportunity to take part in some of the most promising clinical trials in the nation for a broad range of cancers. In fact, Texas Oncology has played an integral role in gaining Food and Drug Administration (FDA) a
'/>"/>

SOURCE Trinity Mother Frances Hospitals and Clinics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Video: Allen Institute for Brain Science Unveils Worlds First Genome-Wide Spinal Cord Atlas
2. Video: Chatto Skincare Unprecedented Breakthrough
3. Video: Worlds Heaviest Man Celebrates Birthday and Weight Loss Milestone
4. Video: The Nevada Division of Insurance Launches 2008 Health Sham Insurance Campaign
5. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
6. Video: GlaxoSmithKline Consumer Healthcare Offers Free Nicotine Lozenges for All Certified Pilots and Air Traffic Controllers to Help Them Safely Quit Smoking
7. Video: ADA 22nd New Dentist Conference: Jazzed in New Orleans
8. Video: Most Americans Dont Know Better Fats Benefit Heart Health
9. Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities
10. Video: Ocean Spray Revitalizes Americans Naturally With Free Fuel for Their Bodies
11. Video: Pediatric Brain Tumor Foundation Gives $6 Million Grant to Duke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...diabetes, and arthritis are among a variety of aut... of white blood cell, called the immune regulatory...s malfunction is when a mutation in the FOXP3 gene...In a new study published online this week in the P...
...cted on mice shows that more copper in everyday di...ducted by scientists at the University of Louisvil...esearch Center. Their studies show that giving co...ress on their over-worked hearts by preventing hea...
...cted by American Academy of Neurology finds that e...providing short-term pain relief for lower back pa...long-term pain relief. To develop the guideline, ...c studies on the topic. According to the guidelin...
...time. An extra hour to enjoy life outside. An extr.../ . What should we do when the clock jukes and ji...aves that regulate our sleep? It’s bad enough for... concept. What about kids, who will want to squeez...
Other Medicine News:Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Use Daylight-saving Change to Practice Healthy Sleep Habits 2
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical In...panded clinical data and new nonclinical data,demo... may be broadly,applicable in DNA- and protein-bas...ancer vaccines. Alain P. Rolland, Pharm.D., Ph.D.,...ent, will present the data today,Wednesday, Octob...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
(Date:10/7/2008)... Study Showed Larazotide Acetate Prevented Immun...n Patients with Celiac Disease, Additional Data In...isease, ORLANDO, Fla., Oct. 7 /- Alb...two clinical studies this week at the American,Col...fic Meeting. Data from,study CLIN 1001-004, the fi...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sci...ire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. (...Inc. (NYSE: FRX ) today announced the presentatio...lotide,s safety and efficacy in 420 patients with,.... Analysis of the data,indicates that once- daily ...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Your belly fat could be making you hungrier 17023 1Your belly fat could be making you hungrier 17023 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 1GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 3The Miracle of Funding by State and Local Pension Plans 17016 1The Miracle of Funding by State and Local Pension Plans 17016 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 1AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 3
...ewswire/ -- A new study,demonstrated that the acti...cg twice a day, may improve symptom relief rates i...pation (IBS-C). These,results were presented as a ...argest annual international meeting of digestive d...eiving lubiprostone were nearly,twice as likely to...
...007 - Results from phase III,clinical trials and f...t the 16th Congress of the European Academy of,Der...ghted the,efficacy and safety profile of alitretin...atients with severe refractory chronic,hand eczema...vere Chronic Hand,Eczema (CHE) refractory or unres...
Other Medicine Technology:New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 2New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 3New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 4New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 5New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 6Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
Portable shields for your safety and convenience.
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures.
0.5 mm Pb protection with height-adjustment for patient and practitioner. Measures 18"L x 24"W adjusts 36" to 56" in height at lowest height (36") bottom hem remains 12" from floor. 5 leg base for ma
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre
Medicine Products: